Images of American sexuality in debates over nonprescription access to emergency contraceptive pills

Obstetrics and Gynecology

Volumn 108, Issue 5, 2006, Pages 1272-1276

  Wynn, L L ^a   Trussell, James ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

DECISION MAKING; DISEASE TRANSMISSION; EMERGENCY CONTRACEPTION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE SYSTEM; HEALTH EDUCATION; HUMAN; MORALITY; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK FACTOR; SAFE SEX; SEXUAL ABUSE; SEXUAL BEHAVIOR; SEXUAL HEALTH; SEXUALITY;

CONTRACEPTIVES, POSTCOITAL; DRUG APPROVAL; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; MORALS; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; SEXUAL BEHAVIOR; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33750497631     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000237193.90586.53     Document Type: Review

References (12)

1. Center for Reproductive Rights. Deposition of Curtis J. Rosebraugh in the case of Annie Tummino et al, Plaintiffs, vs. Andrew C. Von Eschenbach, Acting Commissioner of the Food and Drug Administration, Defendent, in the United States District Court, Eastern District of New York. Washington, DC, July 18, 2006. Transcript available at http://www.reproductiverights.org/pdf/ Rosebraugh_0806.pdf, p. 42. Retrieved August 4, 2006.
2. Wood A, Drazen JM, Greene MF. A sad day for science at the FDA. N Engl J Med 2005;353:1197-9.
3. Grimes D. Emergency contraception: politics trumps science at the U.S. Food and Drug Administration. Obstet Gynecol 2004;104:220-1.
4. Price K. The discursive politics of reproductive health. Anthropology News 2005;46:13.
5. Food and Drug Administration. Joint meeting of the Reproductive Health Drugs and Nonprescription Drugs Advisory Committees, December 16, 2003. Available at http://www.fda.gov/ohrms/dockets/ac/03/transcripts/4015T1.pdf. Retrieved July 28, 2006.
6. Ellertson C, Koenig J, Trussell J, Bull J. How many U.S. women need emergency contraception? Contemp Ob/Gyn. 1997;42:102-28.
7. Mosher WD, Martinez GM, Chandra A, Abma JC, Wilson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Advance data from Vital and Health Statistics, No. 350. Adv Data 2004;350:1-36
8. Association of Reproductive Health Professionals. EC OTC sign-on letter to the FDA. December 4, 2003. Available at http://www.arhp.org/ healthcareproviders/resources/ecresources/ecotcfda.cfm. Retrieved July 28, 2006.
9. Raine TR, Harper CC, Rocca CH, Fischer R, Padian N, Klausner JD, et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA 2005;293:54-62.
10. Gold MA, Wolford JE, Smith KA, Parker AM. The effects of advance provision of emergency contraception on adolescent women's sexual and contraceptive behaviors. J Pediatr Adolesc Gynecol 2004;17:87-96.
11. Harper CC, Cheong M, Rocca CH, Darney PD, Raine TR. The effect of increased access to emergency contraception among young adolescents. Obstet Gynecol 2005;106:483-91.
12. Piaggio G, von Hertzen H, Grimes DA, Van Look PFA. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Lancet 1999;353:721.